Recently, Dr. Bernie Zeiher, president, Development at Astellas, spoke with Gail Thornton from Leaders in Pharmaceutical Business Intelligence (LPBI) for the publication’s new “Leaders in Science” series. During the interview, Zeiher provided his perspective on Astellas’ research and development (R&D) strategy, innovations in the pipeline and accelerating the pace of innovation to address the unmet needs of patients. Read the full interview.